ClinicalTrials.govpublic full text
A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat
colorectal cancer, non-small cell lung carcinoma (adenocarcinoma), triple negative breast cancer, renal cell carcinoma, pdr001, crc, tnbc, nsclc, rcc, immunomodulation, biomarkers, bayesian logistic regression model, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 918229
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.